Adjuvant Therapy in Patients after Cystectomy. (PubMed, Urol Clin North Am) - Oct 2, 2026 - "Carboplatin is inferior to cisplatin in bladder cancer and has not been extensively studied in the adjuvant setting. Adjuvant nivolumab and adjuvant pembrolizumab are recommended by National Comprehensive Cancer Network (NCCN) guidelines for patients with high-risk pathology on radical cystectomy."
Journal • Review • Bladder Cancer • Genito-urinary Cancer • Oncology • Solid Tumor
|
|
Eric J Miller; Jonathan F Anker; Matthew D Galsky; Saad O Atiq
|